KLAUSNER ARTHUR J
Insider CIK 1207790 · NONE Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MNPR Monopar Therapeutics | S Sale | 2025-12-18 | 2025-12-19 | 461 | $68.09 | $31.4K | 8,762 | SEC↗ |
| MNPR Monopar Therapeutics | S Sale | 2025-12-18 | 2025-12-19 | 4,660 | $67.06 | $312.5K | 9,223 | SEC↗ |
| MNPR Monopar Therapeutics | J Other | 2025-12-16 | 2025-12-17 | 7,710 | — | $0 | 13,883 | SEC↗ |
| MNPR Monopar Therapeutics | A Award deriv | 2025-12-02 | 2025-12-08 | 2,924 | — | $0 | 2,924 | SEC↗ |
| MNPR Monopar Therapeutics | A Award deriv | 2025-03-04 | 2025-03-07 | 11,365 | — | $0 | 11,365 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2023-12-31 | 2024-01-03 | 2,533 | — | $0 | 0 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2023-12-31 | 2024-01-03 | 2,533 | — | $0 | 30,863 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2023-09-30 | 2023-10-03 | 2,533 | — | $0 | 2,533 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2023-09-30 | 2023-10-03 | 2,533 | — | $0 | 28,330 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2023-06-30 | 2023-07-03 | 2,534 | — | $0 | 5,066 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2023-06-30 | 2023-07-03 | 2,534 | — | $0 | 25,797 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2023-03-31 | 2023-04-04 | 2,533 | — | $0 | 7,600 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2023-03-31 | 2023-04-04 | 2,533 | — | $0 | 23,263 | SEC↗ |
| MNPR Monopar Therapeutics | A Award deriv | 2023-02-01 | 2023-02-03 | 13,930 | — | $0 | 13,930 | SEC↗ |
| MNPR Monopar Therapeutics | A Award deriv | 2023-02-01 | 2023-02-03 | 10,133 | — | $0 | 10,133 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2022-12-31 | 2023-01-03 | 2,859 | — | $0 | 0 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2022-12-31 | 2023-01-03 | 2,859 | — | $0 | 20,730 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2022-09-30 | 2022-10-03 | 2,859 | — | $0 | 2,859 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2022-09-30 | 2022-10-03 | 2,859 | — | $0 | 17,871 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2022-06-30 | 2022-07-01 | 2,859 | — | $0 | 5,718 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2022-06-30 | 2022-07-01 | 2,859 | — | $0 | 15,012 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2022-03-31 | 2022-04-01 | 2,859 | — | $0 | 8,577 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2022-03-31 | 2022-04-01 | 2,859 | — | $0 | 12,153 | SEC↗ |
| MNPR Monopar Therapeutics | A Award deriv | 2022-02-02 | 2022-02-04 | 11,436 | — | $0 | 11,436 | SEC↗ |
| MNPR Monopar Therapeutics | A Award deriv | 2022-02-02 | 2022-02-04 | 15,128 | — | $0 | 15,128 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2021-12-31 | 2022-01-04 | 751 | — | $0 | 0 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2021-12-31 | 2022-01-04 | 751 | — | $0 | 9,294 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2021-09-30 | 2021-10-01 | 751 | — | $0 | 751 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2021-09-30 | 2021-10-01 | 751 | — | $0 | 8,543 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2021-06-30 | 2021-07-02 | 752 | — | $0 | 1,502 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2021-06-30 | 2021-07-02 | 752 | — | $0 | 7,792 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2021-03-31 | 2021-04-01 | 751 | — | $0 | 2,254 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2021-03-31 | 2021-04-01 | 751 | — | $0 | 7,040 | SEC↗ |
| MNPR Monopar Therapeutics | A Award deriv | 2021-01-26 | 2021-01-28 | 4,443 | — | $0 | 4,443 | SEC↗ |
| MNPR Monopar Therapeutics | A Award deriv | 2021-01-26 | 2021-01-28 | 3,005 | — | $0 | 3,005 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2020-12-31 | 2021-01-05 | 322 | — | $0 | 0 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2020-12-31 | 2021-01-05 | 322 | — | $0 | 6,289 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2020-09-30 | 2021-01-05 | 322 | — | $0 | 322 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2020-09-30 | 2021-01-05 | 322 | — | $0 | 5,967 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2020-06-30 | 2020-07-02 | 323 | — | $0 | 644 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2020-06-30 | 2020-07-02 | 323 | — | $0 | 5,645 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2020-03-31 | 2020-04-01 | 322 | — | $0 | 967 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2020-03-31 | 2020-04-01 | 322 | — | $0 | 5,322 | SEC↗ |
| MNPR Monopar Therapeutics | A Award deriv | 2020-01-31 | 2020-02-20 | 5,646 | — | $0 | 5,646 | SEC↗ |
| MNPR Monopar Therapeutics | A Award deriv | 2020-01-31 | 2020-02-20 | 1,289 | — | $0 | 1,289 | SEC↗ |
| NONE Monopar Therapeutics | A Award deriv | 2018-08-09 | 2018-09-27 | 26,100 | — | $0 | 26,100 | SEC↗ |